Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Apyx Medical (APYX) over the last 15 years, with Q3 2025 value amounting to $425000.0.

  • Apyx Medical's Other Working Capital Changes rose 24274.19% to $425000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$324000.0, marking a year-over-year increase of 6920.15%. This contributed to the annual value of -$857000.0 for FY2024, which is 55585.11% down from last year.
  • According to the latest figures from Q3 2025, Apyx Medical's Other Working Capital Changes is $425000.0, which was up 24274.19% from -$397000.0 recorded in Q2 2025.
  • Apyx Medical's Other Working Capital Changes' 5-year high stood at $1.5 million during Q2 2021, with a 5-year trough of -$1.4 million in Q4 2021.
  • Its 5-year average for Other Working Capital Changes is -$79473.7, with a median of -$241000.0 in 2024.
  • Per our database at Business Quant, Apyx Medical's Other Working Capital Changes surged by 535185.19% in 2021 and then plummeted by 2560000.0% in 2023.
  • Over the past 5 years, Apyx Medical's Other Working Capital Changes (Quarter) stood at -$1.4 million in 2021, then soared by 100.15% to $2000.0 in 2022, then plummeted by 25600.0% to -$510000.0 in 2023, then skyrocketed by 38.24% to -$315000.0 in 2024, then skyrocketed by 234.92% to $425000.0 in 2025.
  • Its last three reported values are $425000.0 in Q3 2025, -$397000.0 for Q2 2025, and -$37000.0 during Q1 2025.